Envestnet Asset Management Inc. lowered its position in Cameco Corporation (NYSE:CCJ – Free Report) (TSE:CCO) by 22.3% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 347,869 shares of the basic materials company’s stock after selling 99,712 shares during the quarter. Envestnet Asset Management Inc. owned approximately 0.08% of Cameco worth $25,823,000 at the end of the most recent reporting period.
A number of other large investors have also recently added to or reduced their stakes in CCJ. Bison Wealth LLC lifted its stake in Cameco by 16.1% in the fourth quarter. Bison Wealth LLC now owns 21,448 shares of the basic materials company’s stock valued at $1,102,000 after acquiring an additional 2,975 shares during the last quarter. Wealth Enhancement Advisory Services LLC lifted its stake in Cameco by 30.4% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 8,183 shares of the basic materials company’s stock valued at $337,000 after acquiring an additional 1,908 shares during the last quarter. DAVENPORT & Co LLC lifted its stake in Cameco by 50.3% in the first quarter. DAVENPORT & Co LLC now owns 15,531 shares of the basic materials company’s stock valued at $639,000 after acquiring an additional 5,200 shares during the last quarter. Private Trust Co. NA lifted its stake in shares of Cameco by 315.2% during the 1st quarter. Private Trust Co. NA now owns 1,229 shares of the basic materials company’s stock worth $51,000 after buying an additional 933 shares during the last quarter. Finally, OneDigital Investment Advisors LLC lifted its stake in shares of Cameco by 13.8% during the 1st quarter. OneDigital Investment Advisors LLC now owns 23,953 shares of the basic materials company’s stock worth $986,000 after buying an additional 2,912 shares during the last quarter. Institutional investors and hedge funds own 70.21% of the company’s stock.
Analysts Set New Price Targets
CCJ has been the subject of a number of research reports. BMO Capital Markets restated an “outperform” rating on shares of Cameco in a research note on Friday, August 29th. Raymond James Financial increased their target price on Cameco to $150.00 in a research note on Wednesday, October 29th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Cameco in a research note on Wednesday, October 8th. President Capital upgraded Cameco from a “neutral” rating to a “buy” rating in a research note on Monday, September 22nd. Finally, Scotiabank reiterated an “outperform” rating on shares of Cameco in a research note on Wednesday, October 29th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Buy” and an average target price of $102.61.
Cameco Price Performance
Shares of Cameco stock opened at $100.93 on Tuesday. The company has a 50-day simple moving average of $85.39 and a two-hundred day simple moving average of $72.14. The stock has a market capitalization of $43.94 billion, a price-to-earnings ratio of 116.01 and a beta of 0.99. The company has a quick ratio of 2.00, a current ratio of 2.96 and a debt-to-equity ratio of 0.15. Cameco Corporation has a twelve month low of $35.00 and a twelve month high of $110.15.
Cameco Profile
Cameco Corporation provides uranium for the generation of electricity. It operates through Uranium, Fuel Services, Westinghouse segments. The Uranium segment is involved in the exploration for, mining, and milling, purchase, and sale of uranium concentrate. The Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate, as well as the purchase and sale of conversion services.
See Also
- Five stocks we like better than Cameco
- Using the MarketBeat Stock Split Calculator
- Semiconductor Supercycle: Why Onsemi Stock Could Double as AI and EV Growth Accelerate
- What Are Some of the Best Large-Cap Stocks to Buy?
- The Best Local Butchers for Thanksgiving [2025 Survey]
- How to Invest in Biotech Stocks
- $134M in Insider Moves: What It Might Mean for KMI, ISRG and QS
Receive News & Ratings for Cameco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cameco and related companies with MarketBeat.com's FREE daily email newsletter.
